AC Immune (ACIU) Interest Coverage Ratio (2015 - 2026)
AC Immune's (ACIU) quarterly Interest Coverage Ratio came in at 227.51 in Q1 2026, down 36.58% year-on-year from 358.7 in Q1 2025, and up 634.23% on a QoQ basis from 42.59 in Q4 2025.
AC Immune (ACIU) Interest Coverage Ratio (2015 - 2026) Analysis & Trends
AC Immune (ACIU) has 12 years of Interest Coverage Ratio data on file, last reported at 227.51 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio fell 36.58% year-over-year to 227.51 in Q1 2026; TTM through Mar 2026 was 362.73, a 161.78% decrease from a year earlier, with the FY2025 full-year figure at 362.92, down 7.85% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 227.51, up from 42.59 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for ACIU reached as high as 631.33 in Q2 2023 and fell as low as 564.18 in Q4 2024.
- Historically, Interest Coverage Ratio has averaged 214.37 across 5 years, with a median of 181.14 in 2023.
- Across the five-year window, Interest Coverage Ratio soared 617.91% in 2023 and plunged 514.25% in 2024, its largest moves.
- Year by year, Interest Coverage Ratio stood at 26.3 in 2022, then surged by 617.91% to 136.19 in 2023, then plunged by 514.25% to 564.18 in 2024, then soared by 92.45% to 42.59 in 2025, then surged by 634.23% to 227.51 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 227.51 in Q1 2026, 42.59 in Q4 2025, and 351.43 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | AC Immune | 225.68 Mn | 225.68 Mn | - | 227.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 227.51 |
| Dec 31, 2025 | -42.59 |
| Sep 30, 2025 | 351.43 |
| Jun 30, 2025 | 387.76 |
| Mar 31, 2025 | 358.70 |
| Dec 31, 2024 | -564.18 |
| Sep 30, 2024 | -220.27 |
| Jun 30, 2024 | 616.50 |
| Mar 31, 2024 | 557.44 |
| Dec 31, 2023 | 136.19 |
| Sep 30, 2023 | 594.85 |
| Jun 30, 2023 | 631.33 |
| Mar 31, 2023 | 181.14 |
| Dec 31, 2022 | -26.30 |
| Sep 30, 2022 | 174.84 |
| Jun 30, 2022 | 157.61 |
| Mar 31, 2022 | 122.27 |
| Dec 31, 2021 | -26.10 |
| Sep 30, 2021 | 112.06 |
| Jun 30, 2021 | 92.52 |